SNT 25.0% 3.0¢ syntara limited

Ann: Change in substantial holding, page-32

  1. 6,948 Posts.
    lightbulb Created with Sketch. 522
    I also think the FDA approval is not a game changer (since the so called " Bronchitol business restructure" did not happen) for the share price, unless Chiesi can do a magical sale figure in US market.
    There is a chance, although remote, that the LOXL2 deal can be announced. But 2+ years already since Gary Philips bragging the drug has drawn huge interests from big pharams, I doubt this is going to happen at all.

    Bone cancer is a new, cool and fancy story, which I guess will last a year or two for these guys enjoying the shareholders' money for their salary and bonus,

    Show the deal and show the money Gary, or you are nothing but a liar.



 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
3.0¢
Change
-0.010(25.0%)
Mkt cap ! $35.82M
Open High Low Value Volume
3.2¢ 3.2¢ 2.8¢ $259.4K 8.631M

Buyers (Bids)

No. Vol. Price($)
4 712543 3.0¢
 

Sellers (Offers)

Price($) Vol. No.
3.2¢ 69320 2
View Market Depth
Last trade - 16.10pm 30/07/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.